Five-year cause-specific survival after meningioma surgery. A nationwide population-based study.

Champeaux-Depond, C; Weller, J; Constantinou, P; Tuppin, P; Froelich, S

Champeaux-Depond, C; Weller, J; Constantinou, P; Tuppin, P; Froelich, S.

Afiliación

Champeaux-Depond C; Department of Neurosurgery, Lariboisière Hospital, 75010 Paris, France; Inserm U1153, Statistics and Epidemiologic Research Center Sorbonne Paris Cité (CRESS), ECSTRRA team, Université de Paris Paris, France. Electronic address: Charles.Champeaux@gmail.com.
Weller J; Agence Régionale de Santé, 2 bis, avenue Georges Brassens, CS 61002, 97743 Saint Denis CEDEX 9, France.
Constantinou P; French National Health Insurance (CNAM), 50, avenue du Professeur André Lemierre, 75986 Paris CEDEX 20, France.
Tuppin P; French National Health Insurance (CNAM), 50, avenue du Professeur André Lemierre, 75986 Paris CEDEX 20, France.
Froelich S; Department of Neurosurgery, Lariboisière Hospital, 75010 Paris, France.

Neurochirurgie ; 68(3): 280-288, 2022 Apr.

Article en En | MEDLINE | ID: mdl-34906556

Asunto(s)

Neoplasias Meníngeas; Meningioma; Neurofibromatosis 2; Adulto; Humanos; Neoplasias Meníngeas/cirugía; Meningioma/patología; Neurofibromatosis 2/cirugía; Procedimientos Neuroquirúrgicos; Estudios Retrospectivos

Palabras clave

Cause-specific survival; Competing risks; Healthcare database; Meningioma; Outcome; SNDS database

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neurofibromatosis 2 / Neoplasias Meníngeas / Meningioma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Neurochirurgie Año: 2022 Tipo del documento: Article Pais de publicación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google